# Replimune Group, Inc.: Form 8-K, filed Feb 27, 2023

- Company: [Replimune Group, Inc.](/companies/repl.md) (CIK 1737953)
- Form: 8-K
- Filed: 2023-02-27
- Accepted by EDGAR: Feb 27, 2023, 08:49 ET
- Period: 2023-02-27
- Accession: 0001104659-23-025680
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737953/000110465923025680/tm237904d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737953/000110465923025680/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737953/000110465923025680/tm237904d1_8k.htm

Filed Feb 27, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-025680. Last ingested by Listed: Nov 6, 2026, 16:43 ET. No prices; not investment advice.